Fullerton Fund Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Fullerton Fund Management's LLY Position: Q1 2026 in Review
Fullerton Fund Management reduced its Eli Lilly (LLY) stake by 4.4% in Q1 2026, selling an estimated $52.7K and leaving 1,137 shares worth $1.05M. The position accounts for 0.08% of the portfolio, ranked #39.
Fullerton Fund Management first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $48.4M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Fullerton Fund Management held 1,137 shares of Eli Lilly worth $1.05M as of Q1 2026.
- Fullerton Fund Management sold 52 Eli Lilly shares in Q1 2026, an estimated $52.7K.
- Eli Lilly made up 0.08% of Fullerton Fund Management's portfolio in Q1 2026, its #39 holding.
- Fullerton Fund Management first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
- Fullerton Fund Management's Eli Lilly position peaked at $48.4M in Q2 2024.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Fullerton Fund Management's 13F filing for Q1 2026, filed 15 May 2026.